DTD1 is an aminoacyl-tRNA editing enzyme that deacylates mischarged D-aminoacyl-tRNAs. It also deacylates mischarged glycyl-tRNA (Ala), protecting cells against glycine mischarging by AlaRS (Alanyl-tRNA synthetase). The enzyme acts via tRNA-based rather than protein-based catalysis, rejecting L-amino acids rather than detecting D-amino acids in the active site . By recycling D-aminoacyl-tRNA to D-amino acids and free tRNA molecules, DTD1 counteracts the toxicity associated with the formation of D-aminoacyl-tRNA entities in vivo and helps enforce protein L-homochirality .
The DTD1 gene is located on chromosome 20 and is also known by several aliases, including C20orf88 and HARS2. The gene is involved in coding for the DTD1 protein, which is essential for the hydrolysis of D-tyrosyl-tRNA (Tyr) into D-tyrosine and free tRNA (Tyr) . The encoded protein binds the DNA unwinding element and plays a role in the initiation of DNA replication .
Mutations or malfunctions in the DTD1 gene can lead to errors in protein synthesis, which may result in various cellular dysfunctions. The enzyme’s role in maintaining the accuracy of tRNA charging is vital for cellular health and function.
Recombinant forms of D-Tyrosyl-tRNA Deacylase 1 are used in research to study its function and potential therapeutic applications. Understanding the enzyme’s mechanism can lead to insights into genetic disorders related to protein synthesis errors and the development of targeted treatments.
For more detailed information, you can refer to resources like GeneCards and UniProt .